Log In
Print
BCIQ
Print
Print this Print this
 

Vimizim, elosulfase alfa (BMN-110) (formerly GALNS)

  Manage Alerts
Collapse Summary General Information
Company BioMarin Pharmaceutical Inc.
DescriptionRecombinant human N-acetylgalactosamine-6-sulfatase
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentRegistration
IndicationMucopolysaccharidosis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today